openPR Logo
Press release

Carcinoembryonic Antigen Market is Trending with CAGR of 6.7% by 2023, Key Players- Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, | Broadcast MRFR

09-04-2018 02:44 PM CET | Health & Medicine

Press release from: Market Research Future

Carcinoembryonic Antigen Market is Trending with CAGR of 6.7%

World Carcinoembryonic Antigen Market report titled “Carcinoembryonic Antigen Market Research Report – Forecast to 2023” is an expert analysis report explores the market by Research Methodology, Segmentation, Key Players, and Major Region in-depth.Carcinoembryonic Antigen Market –Overview

Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations.

Try Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/772

However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician.

In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the market growth.

Carcinoembryonic Antigen Market –Major Key Players

Lee BioSolutions
F. Hoffmann-La Roche Ltd
Quest Diagnostics Incorporated.
Correlogic Systems, Inc
Genway Biotech, Inc.
Abbott.
RayBiotech, Inc.
Abcam plc.
Biocare Medical, LLC
Biocare Medical, LLC.
Carcinoembryonic Antigen Market -Regional Analysis

The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period.

Browse Report Details and in-depth TOC @ https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772

Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period.

Carcinoembryonic Antigen Market -Segmentation

The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others. 

Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others.

Major Points form TOC for Carcinoembryonic Antigen Market Research Report – Forecast to 2023

Major Points form Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Carcinoembryonic Antigen Market, By Type

Chapter 7. Global Carcinoembryonic Antigen Market, By Treatment

Chapter 8 Global Carcinoembryonic Antigen Market, By End User

Chapter 9. Global Carcinoembryonic Antigen Market, By Region

Chapter 10 Company Landscape

Chapter 11 Company Profiles

Chapter 12 MRFR Conclusion

Chapter 13 Appendix

Avail Attractive Discount @ https://www.marketresearchfuture.com/check-discount/772

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carcinoembryonic Antigen Market is Trending with CAGR of 6.7% by 2023, Key Players- Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, | Broadcast MRFR here

News-ID: 1219524 • Views:

More Releases from Market Research Future

Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Billion- 2035 | Trend, Demand, Regional Analysis
Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Bil …
The Drone Identification Market is gaining significant traction in 2026 as unmanned aerial systems (UAS) become more widespread across commercial, governmental, and recreational applications. With drone usage expanding rapidly, there is a pressing need for effective identification, tracking, and management systems that ensure airspace safety, regulatory compliance, and coordinated operations. This demand is driving investment in advanced technologies and solutions that support remote identification, situational awareness, and secure communications within
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CAGR | MRFR
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CA …
The Healthcare BPO (Business Process Outsourcing) Market is experiencing significant growth as healthcare providers increasingly outsource non-core functions to specialized service providers. Healthcare BPO services include medical billing and coding, claims processing, customer care, revenue cycle management, IT support, telehealth support, transcription services, and other administrative functions. Outsourcing enables healthcare organizations to reduce operational costs, improve process efficiency, and focus on core clinical services. Market Overview and Growth Trends As per Market
Hearing Aids Market is expected to reach USD 32.45 billion by 2035 | Major Companies - Oticon, Demant, Eargo, GN Store Nord
Hearing Aids Market is expected to reach USD 32.45 billion by 2035 | Major Compa …
The Hearing Aids Market is experiencing consistent growth as the prevalence of hearing loss increases among both aging and younger populations exposed to noise-related hearing issues. Hearing aids play a critical role in enhancing communication, social interaction, and overall quality of life for individuals with hearing impairment. Advances in digital technology, wireless connectivity, and user-centric designs are further boosting adoption worldwide. Market Overview and Growth Trends As per Market Research Future Analysis,
Free Space Optic Communication Market Size to Soar to USD 10,667.18 Billion by 2035 with Rapid Technological Adoption
Free Space Optic Communication Market Size to Soar to USD 10,667.18 Billion by 2 …
The Free Space Optic Communication Market report provides comprehensive insights into market trends, competitive landscape, growth factors, and opportunities across global regions. Free Space Optic Communication Market Overview The Free Space Optic (FSO) Communication Market is witnessing unprecedented growth due to the increasing demand for high-speed, secure, and wireless optical communication solutions. FSO technology uses light to transmit data through free space, offering advantages over traditional fiber-optic and radio frequency communications, particularly

All 5 Releases


More Releases for Carcinoembryonic

Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: Cr …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market encompassing carcinoembryonic antigen has experienced swift expansion lately, projected to progress from a valuation of $1.22 billion in 2024 to $1.38 billion the following year, reflecting a robust compound annual growth rate of
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The size of the carcinoembryonic antigen market has experienced swift growth in the previous years. There will be an increase from $1.22 billion in 2024 to $1.38 billion in 2025, exhibiting a compound annual growth
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth Dri …
What combination of drivers is leading to accelerated growth in the carcinoembryonic antigen market? The surge in cancer cases is anticipated to fuel the expansion of the carcinoembryonic antigen market in the future. Cancer is an ailment identified by unregulated proliferation and dissemination of irregular cells. The prevalence of cancer is increasing owing to aspects such as lifestyle alternatives, environmental contamination, genetic susceptibility, and a growing elderly population. Carcinoembryonic antigen (CEA)
Carcinoembryonic Antigen Market Analysis, Growth Forecast 2024-2033
The new report published by The Business Research Company, titled ""Carcinoembryonic Antigen Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the carcinoembryonic antigen market size has grown rapidly in recent years. It will grow from $1.07 billion in
Carcinoembryonic Antigen (CEA) Market Size, Share | Industry Report 2026
The global Carcinoembryonic Antigen (CEA) Market was valued at $5.3 Billion in 2018 and is forecast to grow at a modest 6.1 % CAGR between 2018 and 2026, culminating in 2026 global sales of $ 9.2 Billion. Carcinoembryonic AntigenTest is a blood test which identifies the diagnose and manage certain cancer disease like rectum and large intestine. Basically, it is used to check how well treatment is working in certain
Carcinoembryonic Antigen Industry Continues Growth |Quest Diagnostics, GenWay Bi …
The Report “Carcinoembryonic Antigen Market Size By Application, By Gender (Male, Female), By End-user, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024” Carcinoembryonic Antigen Market will reach USD 3.0 billion by 2024 UK carcinoembryonic antigen market is projected to grow at significant CAGR of 6.7% over the forecast time period. Rapidly increasing geriatric population, technological advancements, and growing healthcare expenditure in the